Nightingale Health (FRA:7XE) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:7XE Nightingale Health PLC FRA:7XE
66 GF Score
Price €0.74
GF Value €2.13
! 6 Warning Signs
View Full Analysis

What is Nightingale Health Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

FRA:7XE
66GF Score
Nightingale Health PLC FRA:7XE
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nightingale Health (FRA:7XE) Overvalued in 2026?

Based on GuruFocus' analysis, Nightingale Health stock appears to be undervalued. The current stock price of €0.74 is trading 65.1% below its estimated GF Value™ of €2.13.

Key valuation signals for FRA:7XE:

  • Interest Received:
  • GF Value™: €2.13 vs. price of €0.74 (65.1% below fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the FRA:7XE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nightingale Health Business Description

Other Exchanges NGHLF:USAHEALTH:Finland
Address Mannerheimintie 164a, Helsinki, FIN, 00300
Nightingale Health PLC offers a health data platform that detects disease risks. The Health Data Platform empowers individuals to take actions to prevent diseases by allowing them access to disease risk information. With its Health Data Platform, the company connects the services of healthcare actors with the preventative health needs of individuals. The company operates in Finland, Japan, the United Kingdom, Singapore, and the USA.
66GF Score

Get the complete analysis for FRA:7XE

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.74
Price
€2.13
GF Value